All posts tagged
UK Cannabinoid Company Loses 9% and a Competitor after American Phase II Failure
More “FDA Love” for Cannabis Company with Orphan Drug Designation
Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials
The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge
What to Expect from European Biotech Finance in 2017
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
UPDATE: More Good News on a Cannabis Derivative for Epilepsy
World Mental Health Day: How is Biotech Helping the Cause?
Which European Biotechs made it to the Billion-Euro Club in 2016?
Labiotech UG, All Rights Reserved -
Send this to a friend